Dexcom Inc banner

Dexcom Inc
XMUN:DC4

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
XMUN:DC4
Watchlist
Price: 51.9 EUR 1.17%
Market Cap: €40.1B

Wall St Price Targets

DC4 Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DC4 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DC4 is 76.5 EUR with a low forecast of 62.36 EUR and a high forecast of 100.85 EUR.

Lowest Forecast
Price Target
62.36 EUR
20% Upside
Average Forecast
Price Target
76.5 EUR
47% Upside
Highest Forecast
Price Target
100.85 EUR
94% Upside
Dexcom Inc Competitors:
Price Targets
TEL
TE Connectivity Ltd
28% Upside
H2A
H2APEX Group SCA
203% Upside

Revenue
Forecast

34% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
34% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.

Operating Income
Forecast

N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

The compound annual growth rate for Operating Income over the next 8 years is 16%.

Net Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

The compound annual growth rate for Net Income over the next 5 years is 19%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DC4's stock price target?
Price Target
76.5 EUR

According to Wall Street analysts, the average 1-year price target for DC4 is 76.5 EUR with a low forecast of 62.36 EUR and a high forecast of 100.85 EUR.

What is the Revenue forecast for Dexcom Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.

What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
16%

The compound annual growth rate for Operating Income over the next 8 years is 16%.

What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Net Income over the next 5 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett